FOXM1 and cancer: In this study, we found that STL001 was effective in sensitizing a wide variety of cancer cells to a broad spectrum of anticancer drugs, through FOXM1 suppression, suggesting that FOXM1 is a crucial factor in therapeutic resistance in solid cancer and mediates the effects of STL001 in sensitization of solid cancer to different chemotherapies.